Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update

Applied DNA Sciences, Inc. (NASDAQ:APDN) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 611,100 shares, a decline of 28.4% from the October 15th total of 853,200 shares. Based on an average daily volume of 11,550,000 shares, the short-interest ratio is currently 0.1 days.

Institutional Investors Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Jane Street Group LLC acquired a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned about 0.24% of Applied DNA Sciences as of its most recent filing with the Securities and Exchange Commission (SEC). 22.22% of the stock is currently owned by institutional investors.

Applied DNA Sciences Trading Down 6.8 %

Shares of NASDAQ:APDN opened at $0.16 on Friday. The business has a fifty day simple moving average of $0.60 and a 200 day simple moving average of $1.03. Applied DNA Sciences has a 1 year low of $0.15 and a 1 year high of $22.80. The firm has a market cap of $5.06 million, a price-to-earnings ratio of -0.01 and a beta of 0.46.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Applied DNA Sciences to a “sell” rating in a research report on Tuesday, September 17th.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.